Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 2 |
Apple
AAPL
|
+$931M |
| 3 |
Tesla
TSLA
|
+$793M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$769M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$703M |
| 2 |
Bank of America
BAC
|
+$690M |
| 3 |
Amazon
AMZN
|
+$678M |
| 4 |
JPMorgan Chase
JPM
|
+$601M |
| 5 |
Meta Platforms (Facebook)
META
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.11% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.48% |
| 4 | Healthcare | 0.92% |
| 5 | Communication Services | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
ARK Blockchain & Fintech Innovation ETF
ARKF
$816M
| $4.28M | ﹤0.01% |
+86,026
| New | +$3.88M |
|
|
TRIT
3627
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
| $4.27M | ﹤0.01% |
+387,531
| New | +$4.53M |
|
|
ACB
3628
Aurora Cannabis
ACB
$254M
| $4.27M | ﹤0.01% |
51,429
-13,974
| -21% | -$1.02M |
|
3629
PUT
ProShares VIX Short-Term Futures ETF
VIXY
$216M
| $4.27M | ﹤0.01% |
3,886
+36
| +0.9% | +$47.9K |
|
3630
CALL
Dycom Industries
DY
$8.88B
| $4.27M | ﹤0.01% |
56,500
+16,400
| +41% | +$1.13M |
|
|
SRCL
3631
DELISTED
Stericycle Inc
SRCL
| $4.27M | ﹤0.01% |
61,530
+54,636
| +793% | +$3.74M |
|
3632
PUT
Hormel Foods
HRL
$11.9B
| $4.26M | ﹤0.01% |
91,500
+30,500
| +50% | +$1.49M |
|
3633
PUT
Lattice Semiconductor
LSCC
$16.2B
| $4.26M | ﹤0.01% |
93,000
-2,200
| -2% | -$85.1K |
|
3634
PUT
Healthpeak Properties
DOC
$14.5B
| $4.26M | ﹤0.01% |
140,900
+47,300
| +51% | +$1.38M |
|
3635
CALL
ProShares Ultra Technology
ROM
$1.25B
| $4.25M | ﹤0.01% |
118,800
-33,200
| -22% | -$1.06M |
|
3636
CALL
Shift4
FOUR
$3.47B
| $4.25M | ﹤0.01% |
56,400
-44,900
| -44% | -$2.69M |
|
3637
PUT
Quince Therapeutics
QNCX
$34.3M
| $4.25M | ﹤0.01% |
766
+736
| +2,453% | +$6.52M |
|
3638
Interactive Brokers
IBKR
$43.4B
| $4.25M | ﹤0.01% |
279,136
-262,048
| -48% | -$3.47M |
|
3639
PUT
Sociedad Química y Minera de Chile
SQM
$22.5B
| $4.25M | ﹤0.01% |
86,600
-30,300
| -26% | -$1.28M |
|
|
MTLS
3640
Materialise
MTLS
$406M
| $4.25M | ﹤0.01% |
78,314
+59,864
| +324% | +$2.67M |
|
3641
PUT
Eos Energy Enterprises
EOSE
$1.19B
| $4.25M | ﹤0.01% |
+203,700
| New | +$2.63M |
|
|
CALA
3642
CALL
DELISTED
Calithera Biosciences, Inc
CALA
| $4.25M | ﹤0.01% |
+43,230
| New | +$3.79M |
|
3643
ImmunityBio
IBRX
$8.53B
| $4.24M | ﹤0.01% |
318,123
+156,498
| +97% | +$1.51M |
|
3644
Leidos
LDOS
$17.7B
| $4.24M | ﹤0.01% |
40,343
+32,544
| +417% | +$3.12M |
|
|
LKFT
3645
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
| $4.24M | ﹤0.01% |
42,800
-6,500
| -13% | -$795K |
|
|
RDS.B
3646
CALL
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.24M | ﹤0.01% |
126,000
+68,700
| +120% | +$2.04M |
|
3647
CALL
DXC Technology
DXC
$1.79B
| $4.23M | ﹤0.01% |
164,400
-50,300
| -23% | -$1.07M |
|
3648
Aptiv
APTV
$9.5B
| $4.23M | ﹤0.01% |
32,485
+13,291
| +69% | +$1.48M |
|
3649
Cardlytics
CDLX
$23.7M
| $4.22M | ﹤0.01% |
2,958
+958
| +48% | +$1.02M |
|
3650
PUT
Anterix
ATEX
$1.81B
| $4.22M | ﹤0.01% |
112,300
+12,800
| +13% | +$422K |
|
Similar funds
Jeff Yass's Q4 2020 Portfolio in Review
As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
- Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
- Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
- Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
- Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
- Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.